Component

Rat claudin-16

Rat tight-junction protein of the paracellular magnesium route, measured and unchanged here.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Cyclosporine did not change renal expression of claudin-16 in the same rat model in which it lowered TRPM6, TRPM7, NCC and EGF.

    Cyclosporine → Rat claudin-16 source_derived_draftungraded
    Experimental context and source evidence
    duration
    Not stated here
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    experimental_model
    Rat model of cyclosporine nephrotoxicity
    exposure
    Cyclosporine, dose and duration not stated here
    limitations
    A measured null that places the effect at the distal convoluted tubule rather than at the paracellular magnesium route of the thick ascending limb. Expression was the readout; paracellular permeability was not measured.
    organism
    Rat model of cyclosporine nephrotoxicity
    plain_language
    Cyclosporine did not change renal expression of claudin-16 in the same rat model in which it lowered TRPM6, TRPM7, NCC and EGF.
    primary_references
    Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment. (2011). https://pubmed.ncbi.nlm.nih.gov/21653632/ DOI: 10.1152/ajprenal.00116.2011
    route
    In vivo
    tissue
    Kidney

    Cyclosporine: the complex that inhibits calcineurin, a second cyclophilin, and the transport step that decides exposure (2026-09-23) · lines 278–278

    Original AI-assisted curation of seven primary studies resolved by PubMed title search, with every abstract read and all DOIs cross-checked against live PubMed metadata on 2026-09-23. No reference carries a recorded retraction, erratum or expression of concern. Each of the seven is a separate laboratory and each carries its own lineage key, so none of them can be counted twice as independent support. Study-specific concentrations, kinetic constants and limitations retained. Not publisher full text. · supports · Rat model of cyclosporine nephrotoxicity · source_derived_draft · unverified_draft

    Cyclosporine did not change renal expression of claudin-16 in the same rat model in which it lowered TRPM6, TRPM7, NCC and EGF.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards